Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices 70189 

The MEPS–HC was last approved by 

OMB on December 20th, 2012 and will 

expire on December 31, 2015. The OMB 

control number for the MEPS–HC is 

0935–0118. All of the supporting 

documents for the current MEPS–HC 

can be downloaded from OMB’s Web 

site at. http://www.reginfo.gov/public/

do/PRAViewDocument?ref_nbr=201209- 

0935-001. 

The MEPS is a multi-purpose survey. 

In addition to collecting data to yield 

annual estimates for a variety of 

measures related to health care use and 

expenditures, the MEPS also provides 

estimates of measures related to health 

status, consumer assessment of health 

care, health insurance coverage, 

demographic characteristics, 

employment and access to health care 

indicators. Estimates can be provided 

for individuals, families and population 

subgroups of interest. Data from the 

MEPS–HC are intended for a number of 

annual reports required to be produced 

by the Agency, including the National 

Health Care Quality Report and the 

National Health Care Disparities Report. 

AHRQ proposes to make the following 

changes to questions asked of 

respondents: 

Additions 

Closing—questions pertaining to 

respondent email and administration 

status of the Preventive Care selfadministered questionnaire; 

Re-enumeration—addition of 

questions pertaining to educational 

level attainment and the determination 

of institutional status; 

Provider Probes—determination if 

health care was received in an overnight 

facility; and 

Health Insurance—questions were 

added regarding interaction with the 

health insurance marketplace, 

enrollment through state health 

insurance exchanges, the extent of 

subsidized health insurance, monthly 

premiums, health insurance metal plan 

names, and medical debt. 

Preventive Care—a field test will be 

conducted to assess response lost 

through self-administration. 

Deletions 

Questions were removed from the 

following sections: Access to Care, 

Medical Conditions, Charge Payment, 

Child Preventive Health, Disability 

Days, Emergency Room, Employment, 

Health Status, Health Insurance, 

Hospital Stay, Income, Medical Provider 

Visits, Outpatient Departments, and 

Satisfaction with Health Plan. 

Questions were removed to reduce 

burden and redundancy, and additional 

questions were removed due to 

difficulty in respondent interpretation, 

low frequency in response or minimal 

variation, and limited ability of 

respondent to respond accurately. 

Estimated Annual Respondent Burden 

There are no changes to the current 

burden estimates. 

Estimated Annual Costs to the Federal 

Government 

There are no changes to the current 

cost estimates. 

Request for Comments 

In accordance with the Paperwork 

Reduction Act, comments on AHRQ’s 

information collection are requested 

with regard to any of the following: (a) 

Whether the proposed collection of 

information is necessary for the proper 

performance of AHRQ health care 

research and health care information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: November 13, 2014. 

Richard Kronick, 

Director. 

[FR Doc. 2014–27687 Filed 11–24–14; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–15–14ARR] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Drug Overdose Response Investigation 

(DORI) Data Collections—New— 

National Center for Injury Prevention 

and Control (NCIPC), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

State and local health authorities 

frequently call upon CDC’s National 

Center for Injury Prevention and Control 

(NCIPC) to assist in their response to 

urgent public health problems resulting 

from drug use, misuse, abuse, and 

overdose. When called, NCIPC supports 

the states and local health authorities by 

conducting Drug Overdose Response 

Investigations (DORI), which entails a 

rapid and flexible epidemiological 

response. Urgent requests, such as 

DORIs, depend on the time and 

resources available, number of persons 

involved, and other circumstances 

unique to the urgent conditions at hand, 

and usually involve the development of 

procedures, specific data collection 


wreier-aviles on DSK4TPTVN1PROD with NOTICES
70190 Federal Register / Vol. 79, No. 227 / Tuesday, November 25, 2014 / Notices 

instruments, and the collection of 

critical data. 

This request is for a new generic 

approval to conduct information 

collections during DORIs. A three-year 

clearance is requested to ensure: (1) 

Rapid deployment of data collection 

tools and (2) timely information 

collection of vital information. Of 

particular interest is response to 

increasing trends in, or changing 

characteristics of, overdose from 

prescription drugs (with a special 

interest in opioid analgesics such as 

oxycodone or methadone; 

benzodiazepines such as alprazolam) 

and/or illicit drugs (e.g., heroin). 

Specifically, this request covers 

investigative collections with the 

following aims: (1) To understand 

sudden increases in drug use and 

misuse associated with fatal and 

nonfatal overdoses; (2) to understand 

the drivers and risk factors associated 

with those trends; and (3) to identify the 

groups most affected. This will allow 

CDC to effectively advise states on 

recommended actions to control local 

epidemics. Thus, the ultimate goals of 

these collections are to minimize 

adverse health consequences, provide 

epidemiological data collection support 

to the states and, based on the findings 

from the investigation, appropriately 

assist with implementation of 

prevention and control measures. 

Data is collected by epidemiologists, 

psychologists, medical professionals, 

subject matter experts, and 

biostatisticians. Examples of data 

collection modes that may be employed 

during DORIs include: Archival record 

abstractions and reviews, face-to-face 

interviews, telephone interviews, webbased questionnaires, and selfadministered questionnaires. 

For example, information collected 

through archival chart review from 

hospitals and medical examiners could 

include demographics, drug use history, 

reported medical and mental health 

conditions, place of overdose, place of 

death, drug paraphernalia on the scene, 

mode of administration, observers 

present, naloxone administration, 

hospital admittance, autopsy findings, 

and toxicology results. Information 

collected through interviews with 

representatives from agencies involved 

in preventing, intervening, or 

responding to drug overdose could 

include professional history, personal 

experience with drug overdose cases or 

investigations, prevention or 

intervention efforts engaged in, and 

perceptions of characteristics of, or 

changes in drug overdose cases (e.g., 

transition from opioids to heroin; 

increasing or decreasing rates). 

Collection of information from nonfatal 

overdose victims, and friends and 

family of overdose victims could 

include substance use history, 

prescription drug history, number of 

providers and pharmacies used, pain 

history, co-occurring health conditions 

(e.g., abnormal snoring indicative of 

respiratory depression), mental health 

conditions (e.g., depression, anxiety 

disorders), enrollment in drug treatment 

programs, sources of drugs, route of 

drug administration, and criminal 

history. Finally, collection of spatial 

information could be obtained through 

city, county, and state government 

agencies to determine structural and 

environmental factors associated with 

location of overdose deaths. 

Respondent type will also vary by 

investigation, but will include 

organizations typically involved in 

prevention, intervention, and response 

to drug overdose (e.g., public health, 

law enforcement authorities, health 

systems, and community organizations). 

Respondents also may include victims 

of non-fatal drug overdoses, as well as 

family and friends of victims. 

During a DORI, data is collected once, 

with the rare need for follow-up. There 

are no costs to respondents other than 

their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Drug Overdose Response Investigation Participants.Drug Overdose Response Investigation Data 

Collection Instruments.

2,700 1 .5 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2014–27850 Filed 11–24–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–15–0913] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The notice for 

the proposed information collection is 

published to obtain comments from the 

public and affected agencies. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address any of the 

following: (a) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the functions of the agency, including 

whether the information will have 

practical utility; (b) Evaluate the 

accuracy of the agencies estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; (d) Minimize the burden of 

the collection of information on those 

who are to respond, including through 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and (e) Assess information 

collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Written 

comments and/or suggestions regarding 

the items contained in this notice 

should be directed to the Attention: 

CDC Desk Officer, Office of Management 

and Budget, Washington, DC 20503 or 

by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 


wreier-aviles on DSK4TPTVN1PROD with NOTICES